High Content Imaging System News Today

Due to rising demand for personalized medicine, effective drug discovery, and an increase in the prevalence of chronic diseases, the global organoids and

Meet the 3D cell culture technology that is breaking boundaries in cancer research, drug discovery and beyond

The ImageXpress Confocal HT.ai High-Content Imaging System is a scalable, high-throughput, high-content screening solution with machine learning capabilities.

San Jose, Calif., USA, and ‘s Hertogenbosch, the Netherlands (PRWEB) February 07, 2022 -- Molecular Devices, LLC., an industry leader in 3D biology and

Product News: Molecular Devices introduces the ImageXpress Confocal HT.ai High-Content Imaging System 02 Feb 2021 The ImageXpress Confocal HT.ai High-Content Imaging System combines premium hardware technology with a self-learning software analysis workflow for increased signal and ultra-fast 3D organoid screening. Built on the success of the company’s flagship model, the ImageXpress Confocal, the HT.ai System utilizes a seven-channel laser light source with eight imaging channels to enable h...

  January 28, 2021 January 28, 2021 | New products for high-content imaging, virus reagents and enrichment, software for small molecule design, and pharmacokinetic simulation. Plus: acquisitions in drug discovery services and partnerships for data analysis, single cell analysis, machine learning, and more.   Certara has released version 20 of its Simcyp Physiologically-based Pharmacokinetic (PBPK) Simulator platform. Simcyp PBPK Simulator version 20 offers new and enhanced model...